BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 41 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $29,737,000 | -26.2% | 29,700,000 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $40,303,000 | +27.7% | 29,700,000 | -0.0% | 0.02% | 0.0% |
| Q1 2020 | $31,559,000 | -2.4% | 29,701,000 | 0.0% | 0.02% | +23.5% |
| Q4 2019 | $32,339,000 | +5.5% | 29,701,000 | +0.0% | 0.02% | 0.0% |
| Q3 2019 | $30,660,000 | -8.1% | 29,700,000 | 0.0% | 0.02% | -5.6% |
| Q2 2019 | $33,375,000 | -1.3% | 29,700,000 | 0.0% | 0.02% | 0.0% |
| Q1 2019 | $33,830,000 | +2.2% | 29,700,000 | 0.0% | 0.02% | -10.0% |
| Q4 2018 | $33,116,000 | -7.4% | 29,700,000 | 0.0% | 0.02% | +11.1% |
| Q3 2018 | $35,777,000 | +1.3% | 29,700,000 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $35,332,000 | +7.5% | 29,700,000 | 0.0% | 0.02% | +5.9% |
| Q1 2018 | $32,856,000 | -7.0% | 29,700,000 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $35,324,000 | -1.0% | 29,700,000 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $35,696,000 | +0.6% | 29,700,000 | 0.0% | 0.02% | -5.6% |
| Q2 2017 | $35,473,000 | +0.7% | 29,700,000 | 0.0% | 0.02% | 0.0% |
| Q1 2017 | $35,213,000 | +0.7% | 29,700,000 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $34,953,000 | -6.0% | 29,700,000 | 0.0% | 0.02% | -5.3% |
| Q3 2016 | $37,181,000 | +7.8% | 29,700,000 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $34,489,000 | -2.5% | 29,700,000 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $35,362,000 | -11.2% | 29,700,000 | 0.0% | 0.02% | -5.0% |
| Q4 2015 | $39,835,000 | -0.6% | 29,700,000 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $40,058,000 | -15.6% | 29,700,000 | 0.0% | 0.02% | -9.1% |
| Q2 2015 | $47,446,000 | +3.4% | 29,700,000 | -1.7% | 0.02% | +4.8% |
| Q1 2015 | $45,885,000 | -3.2% | 30,200,000 | -21.6% | 0.02% | 0.0% |
| Q4 2014 | $47,379,000 | +11.9% | 38,500,000 | 0.0% | 0.02% | +10.5% |
| Q3 2014 | $42,350,000 | +40.4% | 38,500,000 | +35.1% | 0.02% | +46.2% |
| Q2 2014 | $30,157,000 | +124.5% | 28,500,000 | +128.0% | 0.01% | +85.7% |
| Q4 2013 | $13,430,000 | – | 12,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 6,195,000 | $9,377,000 | 2.84% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $10,750,000 | 1.09% |
| Man Investments (CH) AG | 1,100,000 | $1,482,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 22,554,000 | $30,444,000 | 0.47% |
| SSI INVESTMENT MANAGEMENT LLC | 3,124,000 | $4,202,000 | 0.45% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 20,000 | $22,373,000 | 0.42% |
| Calamos Advisors LLC | 35,219,000 | $47,628,000 | 0.33% |
| LINDEN ADVISORS LP | 2,500,000 | $3,370,000 | 0.23% |
| Calamos Wealth Management LLC | 513,000 | $694,000 | 0.17% |
| LOOMIS SAYLES & CO L P | 477,810 | $50,323,000 | 0.15% |